Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4027 | 1787 | 37.9 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
39 | 32196 | MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AIDS RELATED LYMPHOMA | Author keyword | 19 | 49% | 2% | 28 |
2 | NON AIDS DEFINING CANCER | Author keyword | 18 | 89% | 0% | 8 |
3 | NON AIDS DEFINING CANCERS | Author keyword | 15 | 77% | 1% | 10 |
4 | HIV ASSOCIATED LYMPHOMA | Author keyword | 13 | 71% | 1% | 10 |
5 | NON AIDS DEFINING MALIGNANCIES | Author keyword | 11 | 69% | 1% | 9 |
6 | HIV RELATED LYMPHOMA | Author keyword | 9 | 83% | 0% | 5 |
7 | AIDS LYMPHOMA | Author keyword | 7 | 57% | 0% | 8 |
8 | AIDS DEFINING MALIGNANCIES | Author keyword | 6 | 100% | 0% | 4 |
9 | HIV ASSOCIATED HODGKIN LYMPHOMA | Author keyword | 6 | 100% | 0% | 4 |
10 | HIV LYMPHOMA | Author keyword | 4 | 67% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INFUSIONAL CYCLOPHOSPHAMIDE | 120 | 91% | 3% | 50 |
2 | AIDS RELATED LYMPHOMA | 89 | 65% | 5% | 85 |
3 | VIRUS RELATED LYMPHOMA | 36 | 83% | 1% | 20 |
4 | HIV ASSOCIATED LYMPHOMA | 27 | 74% | 1% | 20 |
5 | AIDS DEFINING CANCERS | 25 | 58% | 2% | 29 |
6 | AIDS DEFINING MALIGNANCIES | 23 | 59% | 1% | 26 |
7 | DEFINING CANCERS | 18 | 89% | 0% | 8 |
8 | ORAL COMBINATION CHEMOTHERAPY | 14 | 100% | 0% | 7 |
9 | PREDNISONE CHEMOTHERAPY | 13 | 71% | 1% | 10 |
10 | HIGHLY ACTIVE REGIMEN | 11 | 78% | 0% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges | 2014 | 12 | 128 | 40% |
Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: A systematic review | 2015 | 1 | 40 | 75% |
Diagnosis and management of lymphomas and other cancers in HIV-infected patients | 2014 | 8 | 152 | 49% |
ACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED LYMPHOMA | 1992 | 294 | 89 | 46% |
How I treat HIV-associated lymphoma | 2012 | 28 | 83 | 41% |
The Challenge of AIDS-Related Malignancies in Sub-Saharan Africa | 2010 | 29 | 88 | 48% |
Impact of highly effective antiretroviral therapy on the risk for Hodgkin lymphoma among people with human immunodeficiency virus infection | 2012 | 8 | 21 | 67% |
Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk | 2014 | 3 | 79 | 46% |
Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings | 2012 | 10 | 36 | 56% |
Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years | 2011 | 31 | 44 | 43% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REGISTRO TUMORI LIGURE | 4 | 75% | 0.2% | 3 |
2 | STEM CELL ECT PROC UNIT | 4 | 75% | 0.2% | 3 |
3 | CANC REGISTRY CANTON VAUD | 3 | 100% | 0.2% | 3 |
4 | MACERATA PROV CANC MORTAL REGISTRY | 3 | 100% | 0.2% | 3 |
5 | UGANDA CANC | 3 | 35% | 0.3% | 6 |
6 | CELLULAR THER Y HIGH DOSE CHEMOTHER Y UNIT | 2 | 67% | 0.1% | 2 |
7 | INFECT DIS B | 2 | 67% | 0.1% | 2 |
8 | INFECT IMMUNOEPIDEMIOL BRANCH | 2 | 11% | 1.0% | 18 |
9 | REGISTRO TUMORI VENETO | 2 | 23% | 0.4% | 7 |
10 | COORDINAT DATA | 2 | 29% | 0.3% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000290031 | PLASMABLASTIC LYMPHOMA//PLASMABLASTIC//HUMAN IMMUNODEFICIENCY VIRUS NEGATIVE |
2 | 0.0000123847 | CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS//HIV IN WOMEN//CERVICAL DYSPLASIA |
3 | 0.0000107727 | KAPOSIS SARCOMA//HUMAN HERPESVIRUS 8//KAPOSI SARCOMA |
4 | 0.0000102069 | LYMPHOBLASTIC LYMPHOMA//BURKITTS LYMPHOMA//BURKITT LYMPHOMA |
5 | 0.0000100178 | VIETNAM EVIDENCE HLTH POLICY PROJECT//CELL PHONE INTERVENTION//NON AIDS RELATED MORTALITY |
6 | 0.0000080275 | DIFFUSE INFILTRATIVE LYMPHOCYTOSIS SYNDROME//BENIGN LYMPHOEPITHELIAL CYSTS//DILS |
7 | 0.0000076905 | ANAL CANCER//ANAL INTRAEPITHELIAL NEOPLASIA//ANAL CARCINOMA |
8 | 0.0000075667 | PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA//PRIMARY CNS LYMPHOMA//PCNSL |
9 | 0.0000070473 | NELFINAVIR//SAQUINAVIR NO//ANTIRETROVIRALL THERAPY |
10 | 0.0000064164 | AIDS CHOLANGIOPATHY//ANAL DISEASES//ANAL ULCER |